XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). After the mainland of China, South Korea, Australia and ...

Hall of Fame trainer Todd Pletcher faces a pending medication violation for the presence of the controlled substance ...